Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
10.08
-0.67 (-6.23%)
At close: Jul 31, 2026, 4:00 PM EDT
10.21
+0.13 (1.29%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $715.03 million as of July 31, 2026. Its market cap has increased by 7.12% in one year.
Market Cap
715.03M
Enterprise Value
669.73M
1-Year Change
7.12%
Ranking
Category
Stock Price
$10.08
ChartMarket Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $715.03M, an increase of 454.91%. That is a compound annual growth rate of 6.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 715.03M | -37.67% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faeth Therapeutics | 748.87M |
| Phathom Pharmaceuticals | 748.23M |
| SpyGlass Pharma | 747.24M |
| Candel Therapeutics | 736.37M |
| Bright Minds Biosciences | 731.41M |
| Aclaris Therapeutics | 730.44M |
| Climb Bio | 694.00M |
| CytomX Therapeutics | 690.12M |